Perinatal Toxicology Screening: Comparison of Various Maternal and Neonatal Samples

Journal of Perinatology

Volumn 18, Issue 2, 1998, Pages 116-121

  Kim, Ellen ^a,d   Brion, Luc P ^a   Meenan, Gerard ^b   Lehrer, Michael ^b   Suresh, Bangalore R ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c Methodist Hospital   (United States)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

AMNION FLUID; ARTICLE; CHEMISTRY; COCAINE DEPENDENCE; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; NEWBORN; NEWBORN SCREENING; PREGNANCY; SENSITIVITY AND SPECIFICITY; STOMACH JUICE; SUBSTANCE ABUSE; UNITED STATES; URBAN POPULATION; WITHDRAWAL SYNDROME;

AMNIOTIC FLUID; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; GASTROINTESTINAL CONTENTS; HUMANS; INFANT, NEWBORN; MALE; NEONATAL ABSTINENCE SYNDROME; NEONATAL SCREENING; NEW YORK CITY; PREGNANCY; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; URBAN POPULATION;

EID: 0032018754     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Halstead AC, Godolphin W, Lockitch G, Segal S. Timing of specimen collection is crucial in urine screening of drug dependent mothers and newborns. Clin Biochem 1988;21:59-61.
2. Osterloh D, Lee BL. Urine drug screening in mothers and newborns. Am J Dis Child 1989;143:791-3.
3. Ostrea EM, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992;89:107-13.
4. Maynard EC, Amoruso LP, Oh W. Meconium for drug testing. Am J Dis Child 1991;145:650-2.
5. Wingert WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. J Forensic Sci 1994;39:150-8.
6. Lewis DE, Moore CM, Leikin JB, Koller A. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. J Anal Toxicol 1995;19:148-50.
7. Casanova OQ, Lambardero N, Behnke M, Eyler DF, Colon M, Bertholf RL. Detection of cocaine exposure in the neonate: analysis of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch Pathol Lab Med 1994;118:988-93.
8. Blinick G, Inturrisi CE, Jerez E, Wallach RC. Amniotic fluid methadone in women maintained on methadone. Mt Sinai J Med 1974;41:254-9.
9. Jain L, Meyer W, Moore C, Tebbett I, Gauthier D, Vidyasagar D. Detection of fetal cocaine exposure by analysis of amniotic fluid. Obstet Gynecol 1993;81:787-90.
10. O'Connor TA, Ringer KM, Kilbride HW. Cocaine detection in neonatal gastric samples. J Perinatol 1996;16:197-8.
11. Garcia DC, Romero A, Garcia GC, Ostrea EM. Gastric fluid analysis for determining gestational cocaine exposure. Pediatrics 1996;291-3.
12. Moore C, Lewis D, Leikin J. False-positive and false-negative rates in meconium drug testing. Clin Chem 1995;41:1614-6.
13. Mahone PR, Scott K, Sleggs G, D'Antoni T, Woods JR. Cocaine and metabolites in amniotic fluid may prolong fetal drug exposure. Am J Obstet Gynecol 1994;171:465-9.
14. Schulman M, Morel K, Karmen K, Chazotte C. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area. Am J Perinatol 1993:10:374-6.
15. Roe DA, Little BB, Bawdon RE, Gilstrap LC III. Metabolism of cocaine by human placentas: implications for fetal exposure. Am J Obstet Gynecol 1990;163:715-8.